The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy.
Carlo ChiesaK Sjogreen GleisnerG FluxJ GearS WalrandK BacherU EberleinE P VisserN ChouinM LjungbergM BardièsM LassmannL StrigariM W KonijnenbergPublished in: European journal of nuclear medicine and molecular imaging (2017)